Evidence map›Paper›PMID 31142786›Full record

ArticleScientific reports2019

Herbo-mineral formulation 'Ashwashila' attenuates rheumatoid arthritis symptoms in collagen-antibody-induced arthritis (CAIA) mice model.

Acharya Balkrishna, Sachin Shridhar Sakat, Kheemraj Joshi, Sandeep Paudel, Deepika Joshi, Kamal Joshi, Ravikant Ranjan, Abhishek Gupta, Kunal Bhattacharya, Anurag Varshney

Open access · goldAbstract readComparative Study
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
6.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Acharya BalkrishnaDrug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar, 249 405, Uttarakhand, India.
Sachin Shridhar SakatDrug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar, 249 405, Uttarakhand, India.
Kheemraj JoshiDrug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar, 249 405, Uttarakhand, India.
Sandeep PaudelDrug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar, 249 405, Uttarakhand, India.
Deepika JoshiDrug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar, 249 405, Uttarakhand, India.
Kamal JoshiDrug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar, 249 405, Uttarakhand, India.
Ravikant RanjanDrug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar, 249 405, Uttarakhand, India.
Abhishek GuptaDrug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar, 249 405, Uttarakhand, India.
Kunal BhattacharyaDrug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar, 249 405, Uttarakhand, India.
Anurag VarshneyDrug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar, 249 405, Uttarakhand, India. anurag@prft.co.in.
Patanjali Research Foundation · INHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder that affects joints of hands and feet and introduces injury in secondary organs such as cardiac tissue. In the present study, we induced RA in male Balb/c mice (CAIA) using collagen-antibody cocktail (C-Ab) and lipopolysaccharide intraperitoneal injections. Induction of RA in the animals was detected through the loss of body weight, food, and water consumption, pedal edema, increased arthritis score of the paw and ankle, increase in radiological and histological lesion score of ankle and knee joints and enhanced pain perception in the C-Ab induced RA animals. Ashwashila is a herbo-mineral medicine from Indian Ayurvedic system. Human equivalent doses of Ashwashila (ASHW) and standard of care, Methotrexate were given to the CAIA animals for two weeks. ASHW treatment significantly reversed the effect of C-Ab with reduced pedal edema, arthritis score, radiological and histological lesion scores in ankle-joint, knee-joint and articular cartilage, reduced pain perception. These effects were comparable with the Methotrexate treatment. In human monocytic (THP-1) cells, ASHW was found to be biocompatible at in-vitro test doses. The anti-arthritis mechanism of action for ASHW was established through the suppression of pro-inflammatory cytokines such as IL-1β, IL-6, TNF-α; and upstream regulator, NF-κB. Taken together, we show the pre-clinical efficacy of ASHW in reducing RA associated symptoms by controlling inflammation and suggest it as a potential therapeutic candidate for rheumatoid arthritis.

Indexed as

AnimalsAntirheumatic AgentsArthritis, ExperimentalArthritis, RheumatoidCytokinesDrug Evaluation, PreclinicalHumansInflammation MediatorsMaleMedicine, AyurvedicMethotrexateMiceMineralsPlant ExtractsSignal TransductionTHP-1 CellsAntirheumatic AgentsCytokinesInflammation MediatorsMethotrexateMineralsPlant Extracts

Identifiers

PMID31142786
PMCPMC6541602
OpenAlexW2946846310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.